The use of tissue plasminogen activator in postvitrectomy cases
- 1 April 1993
- journal article
- Published by Springer Nature in International Ophthalmology
- Vol. 17 (2), 95-100
- https://doi.org/10.1007/bf00942782
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Retinal Toxicity of Human Tissue Plasminogen Activator in Vitrectomized Rabbit EyesArchives of Ophthalmology (1950), 1991
- Intraocular Penetration of Topical Tissue Plasminogen ActivatorArchives of Ophthalmology (1950), 1991
- Lack of Effectiveness of Tissue Plasminogen Activator 20 or More Days After VitrectomyArchives of Ophthalmology (1950), 1991
- Intravitreal Tissue Plasminogen Activator Treatment of Experimental Vitreous HemorrhageArchives of Ophthalmology (1950), 1989
- TISSUE PLASMINOGEN ACTIVATOR IN THE TREATMENT OF EXPERIMENTAL RETINAL VEIN OCCLUSIONRetina, 1989
- Filtering Bleb Thrombolysis with Tissue Plasminogen ActivatorAmerican Journal of Ophthalmology, 1988
- Treatment of Postvitrectomy Fibrin Formation With Intraocular Tissue Plasminogen ActivatorArchives of Ophthalmology (1950), 1988
- Use of Tissue Plasminogen Activator in Experimental HyphemaArchives of Ophthalmology (1950), 1987
- Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.Circulation, 1986
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984